Oregon Urology Institute’s Post

🔬 We're proud to share our latest manuscript comparing the effectiveness of aquablation and holmium laser enucleation of the prostate (HoLEP) for treating lower urinary tract symptoms (LUTS) due to benign prostate hyperplasia (BPH). 📊 Our prospective cohort study included 40 patients who chose either aquablation or HoLEP between June 2020 and April 2022. We meticulously analyzed outcomes including prostate volume, uroflowmetry, and quality of life indices over 12 months. 🕒 Findings revealed that while both treatments significantly improved LUTS, HoLEP was superior in operation time and had a better safety profile. However, aquablation showed early benefits in ejaculatory and continence functions at the three-month mark. 🧐 This study provides valuable insights into the surgical options for LUTS. A must-read for healthcare professionals involved in urological care! 🔗 https://lnkd.in/exRyEGHP #Urology #SurgicalInnovation #ProstateHealth #BPH #MedicalResearch #Healthcare #HoLEP #Aquablation Feel free to share and comment! Let's discuss! 🗨️💡

🚀 Kranus Health: 2023 Year in Review 🌟 Reflecting on a year of breakthroughs and progress, let's celebrate Kranus Health's key milestones from 2023 once again 🚀 Multi-Product Expansion: Launch of our second digital therapy Kranus Lutera for lower urinary tract symptoms (due to BPH or OAB) and Kranus Mictera for female incontinence 🇫🇷 French Market Launch: Entered France and setting up our local team, advancing our global virtual urology care mission 🔬 Outstanding clinical results for Kranus Lutera: A major clinical trial achieving all endpoints highlighting our commitment to evidence-based digital therapies in urology 🎉 Growing Urology network: Our urologist network is thriving, with hundreds of urologists prescribing our digital therapies supported by our active involvement in numerous conferences and congresses 💰 Securing $15M in total Series A Funding: Raising $15M to further our mission in providing virtual care in urology and expanding our global footprint 🌐 Global Engagement across US & EU: Participation in various international conferences, webinars, podcasts and media features 🎂 Third Anniversary: Celebrating three years of innovation in urology A heartfelt thank you to our team, partners, and patients. Your support fuels our mission. Excited for 2024, we're geared up for more groundbreaking work in providing virtual care in urology.

As private equity groups continue to acquire urology practices, their footprint and influence in the urology channel are expanding. Here’s what oncology manufacturers need to know about private equity’s growing role: https://ow.ly/Nfe250QLBEw.

| EVMS a Division of Vertice Enriching Lives Through Innovative MedTech | Vertice hits media again with its latest medical achievement at Life Rosepark Hospital, Bloemfontein. The hospital performed its first Holmium laser enucleation of the prostate (HoLEP) procedure (a first in the Free State), revolutionising the treatment of urinary obstruction caused by benign prostatic hyperplasia (BPH) in men. Thanks to this cutting-edge MedTech solution, patients can now experience a better quality of life, free from the frustrating and uncomfortable symptoms caused by an enlarged prostate. One of the most significant advantages of this laser prostatectomy is that it allows for more tissue to be removed with minimal blood loss and is performed endoscopically, without any incision. As result, patients can bid farewell to prolonged hospital stays, as they can have their urinary catheters removed earlier and be discharged sooner. We salute the team of medical personnel at Life Rosepark Hospital for their commitment to embracing innovation and pushing the boundaries of medical excellence. Read the article here: https://lnkd.in/dUZ6Ne_p #VMTG #Vertice #Urology #MedTech #Innovation #HealthcareHeroes #BetterQualityOfLife #Inspiration #MedicalBreakthrough

🎉Celebrating 2023 Urology Team Achievements! 🎉 Florida Cancer Specialists & Research Institute and Florida Healthcare Specialists and Cleveland Clinic Florida It is with great pride and excitement that I share the remarkable 2023 accomplishments of our urology team over the past year. 🏥 In the past year, our clinic has welcomed almost 1900 new patients, providing essential care and support to individuals in need. Additionally, we successfully performed 500 surgeries, demonstrating our team's exceptional surgical skills and unwavering focus on patient outcomes and well-being. 📚 On the research front, our team's contributions have been nothing short of outstanding. We have proudly published 3 peer-reviewed publications, submitted 7 abstracts for consideration at esteemed conferences, and delivered 15 webinars and 7 impactful presentations at international urology events. Furthermore, our expertise has been recognized through the publication of a chapter in a robotic surgery book, solidifying our position in the field of pelvic floor disorders and urology. 👏 These achievements are a testament to the dedication and talent of our urology team. Each member has played a vital role in our collective success, and it is through our collaboration, passion, and unwavering commitment that we have been able to accomplish so much. In the words of Carl Jung, "You are what you do, not what you say you'll do." Let's embody this philosophy as we embark on 2024 and continue to make a positive difference in the lives of those we serve. #TeamAchievements #UrologyExcellence #PatientCare #ResearchInnovation #CarlJung #QuoteOfTheDay

Who’s ready to visit BK Medical at #USANZ24?   Come explore bkFusion*, our fast,1 flexible, and effective2 MRI-ultrasound fusion prostate biopsy solution. Our intraoperative ultrasound systems and transducers for urology will also be on display.   Learn more about our high-resolution imaging solutions for surgical urology guidance: https://lnkd.in/gGak9NF9   *bkFusion is powered by MIM Software.   #GEHealthCare #BKMedical #bkUrology   1 Data on file 2 Immerzeel J., Israël B., Bomers J., et al. Multiparametric Magnetic Resonance Imaging for the Detection of Clinically Significant Prostate Cancer: What Urologists Need to Know. Part 4: Transperineal Magnetic Resonance–Ultrasound Fusion Guided Biopsy Using Local Anesthesia. Journal of European Urology. 2021.  

Extraperitoneal Lap Radical #Prostatectomy with PLND for #CaProstate Operating time 2.5 Hrs Patient walks after 12 Hrs Sent home after 24 Hrs. #Extraperitoneal approach is extremely safe due to lesser impact on cardiac parameters earlier bowel recovery and lesser post operative pain compared to conventional #transperitoneal approach. Complete Bladder neck preservation allowed excellent continence after catheter removal. Excellent team effort by Urology and Anaesthesia #team. #oncology #cancer #cure #prostate #laparoscopy #robotic

Our study in the Canadian Journal Of Urology reveals the remarkable potential of NGS in detecting resistant bacteria linked to urinary tract infections (UTIs). 🦠✨ With its high sensitivity, NGS enables precise and personalized diagnoses, paving the way for tailored treatments. Discover the groundbreaking possibilities and enhance your UTI management. Read the full study now! https://loom.ly/52vcXOk

Our urology team is the first in the East of England and only the fourth NHS hospital trust nationwide to offer a new image-guided robotic treatment to men with enlarged prostates. NNUH urologists joined their counterparts at Guy’s and St Thomas’, the Royal Berkshire and Basingstoke and North Hampshire NHS Trusts in providing Aquablation to men with enlarged prostates who meet the criteria. Aquablation is a robotic procedure that uses a high-pressure saline solution to remove tissue from an enlarged prostate. It has been shown in multiple trials to have fewer side effects including preserving sexual function, than the more common TURP (Transurethral Resection of the Prostate) procedure that involves cutting away the section of the prostate using heat. It has reduced operating time and length of stay. It can be up to 45% faster to carry out the procedure (30-40 minutes compared with 70-80 minutes for the TURP procedure) and some patients go home the same day or stay just one night. Most men have the catheter removed the next day, which improves patient experience and helps bed capacity. Read more on our website: https://lnkd.in/eHtF5edq

𝗥𝗲𝘃𝗼𝗹𝘂𝘁𝗶𝗼𝗻𝗶𝘇𝗶𝗻𝗴 𝗣𝗿𝗼𝘀𝘁𝗮𝘁𝗲 𝗧𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁𝘀: 𝗧𝗵𝗲 𝗦𝗰𝗵𝗲𝗹𝗶𝗻 𝗖𝗮𝘁𝗵𝗲𝘁𝗲𝗿® 𝗮𝗻𝗱 𝗖𝗼𝗿𝗲𝗧𝗵𝗲𝗿𝗺® 💡 In Paper V of VIII from my thesis published in March 2002, the debut of the Schelin Catheter® marked a transformative moment in prostate treatments. The study delved into the outcomes of the first 15 patients who underwent CoreTherm® (PLFT®) using this catheter for sterile transurethral injections with a local anesthetic solution, significantly elevating patient comfort. 𝗛𝗲𝗿𝗲'𝘀 𝘁𝗵𝗲 𝗯𝗿𝗲𝗮𝗸𝘁𝗵𝗿𝗼𝘂𝗴𝗵: • Sterile injections of 0.5% Mepivacain with Adrenaline at strategic prostate locations 🎯 • An 80% reduction in the need for post-treatment analgesics 💊 • Halving of the treatment time ⏱ • A 50% drop in calculated intraprostatic blood flow, thanks to adrenaline's vasoconstrictive effect 🩸 • 62% less total microwave energy required 🔋 • A 35% reduction in prostate volume after 3 months, outperforming the 29% in the non-local anesthesia group 📉 The introduction of sterile injections via the Schelin Catheter® and the targeted use of adrenaline not only maximized patient comfort but also significantly enhanced treatment efficacy by managing blood flow. Keen on exploring these pioneering techniques and their impact on urology treatments? 𝘐 𝘪𝘯𝘷𝘪𝘵𝘦 𝘺𝘰𝘶𝘳 𝘤𝘰𝘮𝘮𝘦𝘯𝘵𝘴 𝘢𝘯𝘥 𝘲𝘶𝘦𝘴𝘵𝘪𝘰𝘯𝘴 𝘧𝘰𝘳 𝘧𝘶𝘳𝘵𝘩𝘦𝘳 𝘥𝘪𝘴𝘤𝘶𝘴𝘴𝘪𝘰𝘯. https://lnkd.in/dCCpDmSi #SchelinCatheter #CoreTherm #Urology #MedicalInnovation #PatientCare #TherapeuticAdvancement